Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

INFINITY™ With ADAPTIS™ Technology Study

NCT: NCT04594993 · ACTIVE_NOT_RECRUITING

NCT IDNCT04594993
StatusACTIVE_NOT_RECRUITING
Start Date2021-02-09
Completion2035-11

Brief Summary

INFINITY™ with ADAPTIS™ Technology Total Ankle Replacement Follow-up (ITAR2) - Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 200 patients with up to 13 sites

Frequently Asked Questions

What is INFINITY™ With ADAPTIS™ Technology Study?

INFINITY™ With ADAPTIS™ Technology Study is a clinical trial registered under NCT04594993. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04594993?

The current status of NCT04594993 (INFINITY™ With ADAPTIS™ Technology Study) is: ACTIVE_NOT_RECRUITING.

When did INFINITY™ With ADAPTIS™ Technology Study start?

INFINITY™ With ADAPTIS™ Technology Study started on 2021-02-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.